Paulo Bergerot on a Remote Exercise Program for lung cancer patients on ICI’s at WCLC24 – Florez Lab

Florez Lab shared on X:

“Dr. Paulo Bergerot will present his research on a Remote Exercise Program for lung cancer patients on immune checkpoint inhibitors at WCLC24.

This innovative study is poised to change the way we approach patient care. Stay tuned for updates!”

Source: Florez Lab/X

More posts featuring WCLC24 on oncodaily.com

Paulo G. Bergerot, MD, is a medical oncologist and post-doctoral fellow at the Department of Medical Oncology at City of Hope Comprehensive Cancer Center in California, USA. His research interests include genomics, psycho-oncology, personalized medicine, shared decision making, and clinical oncology.